No Data
Si Realizó Consultas De Búsqueda En El Sitio Web De Labcorp Entre El 1 De Mayo De 2021 Y El 1 De Abril De 2026, La Conciliación De Una Demanda Colectiva Podría Concernirle.
GREENSBORO, N.C., 4 de septiembre de 2026 /PRNewswire-HISPANIC PR WIRE/ -- ¿DE QUÉ SE TRATA ESTO? Los demandantes alegan que Labcorp violó las leyes de intervención de comunicaciones de
Clinical Trials Services Market Worth $97.41 Billion by 2031 - Exclusive Report by MarketsandMarkets
DELRAY BEACH, Fla., Sept. 4, 2026 /PRNewswire/ -- According to MarketsandMarkets, the Clinical Trials Services Market is projected to reach USD 97.41 billion by 2031 from USD 66.20 billion in 2026,
Evercore Maintains Labcorp Holdings(LH.US) With Buy Rating, Raises Target Price to $340
Evercore analyst Elizabeth Anderson CFA maintains $Labcorp Holdings(LH.US)$ with a buy rating, and adjusts the target price from $300 to $340.According to TipRanks data, the analyst has a success
Analysts' Top Healthcare Picks: Milestone Pharmaceuticals (MIST), Labcorp Holdings (LH)
Argus Adjusts Price Target on Labcorp Holdings to $370 From $310, Keeps Buy Rating
Labcorp Holdings (LH) has an average rating of overweight and mean price target of $344.73, according to analysts polled by FactSet.
Labcorp Announces Enhanced Global Trial Connect Platform for Sponsors, Investigator Sites
Labcorp (LH) has launched an enhanced version of its Global Trial Connect clinical trial platform, adding digital tools for better study visibility and simplifying workflows, the company said Monday.